Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

VR sickness? try VR therapy: study tests virtual rehab for motion sickness

NCT ID NCT07318142

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a 4-week virtual reality exercise program to help people who get motion sickness from visual cues, like in VR or certain videos. 46 adults, some with and some without motion sickness, took part. The program used 360-degree travel videos in a VR headset to gradually build tolerance. Researchers measured symptoms like dizziness and nausea before and after the program to see if it helped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

46 people

The number who actually took part.

Started

Jun 2024

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 30 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: General Inclusion Criteria (n = 46) * Aged between 18 and 30 years * No history of otologic surgery * No history of orthopedic surgery related to the lower extremities * No claustrophobia * Female participants not in menstrual or premenstrual periods * No diagnosed neurological disorders/diseases (e.g., MS, epilepsy, cerebrovascular accident, etc.) * No diagnosed peripheral vestibular pathologies such as Meniere's disease, BPPV, or vestibular neuritis (participants' lack of peripheral vestibular pathology confirmed by audiovestibular vHIT testing) * No spontaneous nystagmus Study Group (21.8 ± 2.9 years, n = 23) Inclusion Criteria VIMSSQ Questionnaire: Participants answered "occasionally" or "frequently" to Question 2 Control Group (23.7 ± 3.3 years, n = 23) Inclusion Criteria GUHHYSA Questionnaire: Participants answered "never" to Question 2 Exclusion Criteria: * History of otologic surgery * History of orthopedic surgery in the lower extremities * Presence of claustrophobia * Female participants in menstrual or premenstrual periods * Diagnosed neurological disorders/diseases (e.g., MS, epilepsy, cerebrovascular accident, etc.) * Diagnosed peripheral vestibular pathologies such as Meniere's disease, BPPV, or vestibular neuritis (as confirmed by audiovestibular vHIT testing) * Presence of spontaneous nystagmus * Participants who did not sign the informed consent form

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Motion sickness, space are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Istanbul Aydin University

    Istanbul, Istanbul, 34295, Turkey (Türkiye)